|
Market Closed -
Nasdaq
04:00:00 29/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 752.25 USD | -4.54% |
|
-5.75% | -2.54% |
| Market Cap | 75.12B 66.06B 62.47B 56.66B 106B 7,210B 107B 748B 289B 3,679B 282B 276B 11,823B | P/E 2026 * |
17.1x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 67.94B 59.76B 56.51B 51.25B 96.25B 6,522B 96.81B 677B 261B 3,328B 255B 250B 10,695B | EV / Sales 2026 * |
4x | EV / Sales 2027 * | 3.51x |
| Free-Float |
71.06% | Yield 2026 * |
0.52% | Yield 2027 * | 0.58% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Tradegate
| RGO | Real-time | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
London S.E.
| 0R2M | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -4.54% | ||
| 1 week | -5.75% | ||
| Current month | -5.86% | ||
| 1 month | -5.28% | ||
| 3 months | +18.86% | ||
| 6 months | +1.97% | ||
| Current year | -2.54% |
| 1 week | 750 |  | 813.53 |
| 1 month | 750 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.54% | -5.75% | +33.40% | -9.86% | 78.69B | |
| -0.80% | +14.07% | +705.55% | +96.75% | 79.4B | |
| +0.26% | +0.92% | -8.35% | -27.28% | 59.52B | |
| -0.89% | +0.19% | +7.92% | +172.79% | 46.58B | |
| +2.49% | -0.14% | -8.95% | +33.71% | 46.53B | |
| +0.48% | +4.39% | +66.48% | -11.30% | 33.63B | |
| +0.75% | +0.14% | +50.93% | +112.97% | 25.11B | |
| -3.56% | -6.10% | +3.11% | +140.98% | 22.13B | |
| +0.73% | -0.95% | +61.19% | +97.04% | 15.31B | |
| +1.00% | -0.98% | -26.57% | +382.01% | 12.82B | |
| Average | -0.31% | +1.44% | +88.47% | +98.78% | 41.97B | |
| Weighted average by Cap. | -0.66% | +2.16% | +148.40% | +64.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.98B 14.93B 14.12B 12.81B 24.05B 1,629B 24.19B 169B 65.28B 831B 63.73B 62.35B 2,672B | 18.54B 16.3B 15.42B 13.98B 26.26B 1,779B 26.41B 185B 71.29B 908B 69.59B 68.08B 2,918B |
| Net income | 4.84B 4.25B 4.02B 3.65B 6.85B 464B 6.89B 48.18B 18.61B 237B 18.16B 17.77B 762B | 5.44B 4.79B 4.53B 4.1B 7.71B 522B 7.75B 54.18B 20.93B 267B 20.43B 19.99B 856B |
| Net Debt | -7.17B -6.31B -5.96B -5.41B -10.16B -688B -10.22B -71.42B -27.58B -351B -26.93B -26.34B -1,129B | -10.05B -8.84B -8.36B -7.58B -14.24B -965B -14.33B -100B -38.67B -493B -37.75B -36.93B -1,583B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | US$752.25 | -4.54% | 1,149,821 |
| 25/09/26 | US$788.04 | -1.00% | 592,145 |
| 24/09/26 | US$796.02 | -0.72% | 602,653 |
| 23/09/26 | US$801.82 | -0.26% | 721,110 |
| 22/09/26 | US$803.90 | +0.72% | 600,266 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
